The Cardiology Division offers a wide range of research projects to our fellows. We have outstanding clinical research opportunities. We are the home to the world's most successful sudden death arrhythmia research group, the Heart Research Follow-up Program. This research team leads the MADIT series of trials and other leading clinical studies in devices which treat lethal arrhythmias and conduction system defects.
The Cardiology Division also offers basic research within the Aab Cardiovascular Research Institute (CVRI). A wide range of basic science projects are available at the CVRI, including research into vascular biology, heart failure, and ion channels. The CVRI also is home to the URMC Howard Hughes Medical Institute (HHMI) Med-into-Grad Graduate Program for translational biomedical research.
View our Division research pages.
“Code Blue” Equals Lower Survival for Cancer Patients
Tuesday, August 01, 2017
Patients with advanced cancer who suffer cardiac arrest in the hospital have a survival rate of less than 10 percent—half the rate of other patients without cancer, according to a nationwide study led by the University of Rochester Medical Center.
The data helps to clear up some myths in medicine about cardiac arrest survival and can be used as a guidepost when hospitalized cancer patients and their families consider do-not-resuscitate (DNR) orders, said Jeffrey T. Bruckel, M.D., a third-year postdoctoral fellow in cardiology at URMC, who led the research.
“We’re hopeful that our study in some way will help doctors and cancer patients make more informed decisions about the end of life,” Bruckel said. “It’s very important to have early, frank, discussions around the goals of care.”
The study was published by the Journal of Oncology Practice in a special end-of-life care edition.
Read Full Article
Gleber C, Yoruk A, Eastburg L, Goldman BI and Cameron SJ. Conduction Dysfunction and Near Expunction: Giant Cell Myocarditis. Am J Med. 2018.
Elbadawi A, Wright C, Patel D, Chen YL, Mazzillo J, Cameron P, Barnes GD and Cameron SJ. The impact of a multi-specialty team for high risk pulmonary embolism on resident and fellow education. Vasc Med. 2018;23:372-376.
Miller E, Izzo C. Exercise and Women’s Heart Health. periFACTS OB/GYN Academy. 2017 October.
Seif E, Chen L, Goldman B. MD. Fulminant Myocarditis; a review of the current literature. US Cardiology Review (USC) issue 12.1, 2018.
Morris JH, Bisognano JD. Masked Hypertension: Finding Trouble Under the Disguise. Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). pii: e003945. doi: 10.1161/CIRCOUTCOMES.117.003945. No abstract available. PMID: 28698193
Lee, E.C, Martens, J, Alexis, J, Gosev, I, and Vidula, H. Outcomes of Long-Term Inotrope Therapy as a Bridge to Heart Transplant. International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions; April 12, 2018; Nice, France.
Lee, E.C. and Cameron, S.J. Cancer and thrombotic risk: The platelet paradigm. Front Cardiovasc Med. 2017 Nov. 4:67.
Naqvi SY, Salama IG, Yoruk A, Chen L. Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure. Card Fail Rev. 2018 May;4(1):43-45. doi: 10.15420/cfr.2018:22:1. Review.
Saha T, Naqvi SY, Goldberg S. Hybrid Revascularization: A Review. Cardiology. 2018 May 7;140(1):35-44. doi: 10.1159/000488190. [Epub ahead of print]
Kutyifa V, Naqvi SY, Brown M, McNitt S, Goldenberg I, Klein H, Moss AJ. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]). Am J Cardiol. 2018 Jun 15;121(12):1567-1574. doi: 10.1016/j.amjcard.2018.02.040. Epub 2018 Mar 14.
Naqvi SY, Wittlin SD, Schwartz RG. Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges. J Nucl Cardiol. 2018 Feb 5. doi: 10.1007/s12350-017-1177-4. [Epub ahead of print] No abstract available.
Naqvi SY, Klein J, Saha T, McCormick DJ, Goldberg S. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease. Am J Cardiol. 2017 Feb 15;119(4):520-527. doi: 10.1016/j.amjcard.2016.11.003. Epub 2016 Nov 16. Review.
Joseph J, Naqvi SY, Giri J, Goldberg S. Aortic Stenosis: Pathophysiology, Diagnosis, and Therapy. Am J Med. 2017 Mar;130(3):253-263. doi: 10.1016/j.amjmed.2016.10.005. Epub 2016 Nov 1. Review.
Saha T, Naqvi SY, Ayah OA, McCormick D, Goldberg S. Subclavian Artery Disease: Diagnosis and Therapy. Am J Med. 2017 Apr;130(4):409-416. doi: 10.1016/j.amjmed.2016.12.027. Epub 2017 Jan 19. Review.
Bennett AL, Lavie CJ, Grace SL. Cardiac Rehabilitation Following Acute Coronary Syndrome in Women. Curr Treat Options Cardiovasc Med. 2017 Aug;19(8):57. doi: 10.1007/s11936-017-0559-x. Review. PMID: 28624885
Ghisi GLM, Chaves GSDS, Bennett A, Lavie CJ, Grace SL. The Paucity of Data Addressing the Effects of Cardiac Rehabilitation on Mortality and Morbidity in Women. Can J Cardiol. 2018 Apr;34(4):502.e1-502.e2. doi: 10.1016/j.cjca.2017.11.001. Epub 2017 Nov 3. PMID: 29289403
Lavie CJ, Bennett A, Arena R. Enhancing Cardiac Rehabilitation in Women. J Womens Health (Larchmt). 2017 Aug;26(8):817-819. doi: 10.1089/jwh.2017.6476. Epub 2017 Jun 14. PMID: 28613967
Bennett AL, Lavie CJ. Vitamin D Metabolism and the Implications for Atherosclerosis. Adv Exp Med Biol. 2017;996:185-192. doi: 10.1007/978-3-319-56017-5_15. Review. PMID: 29124700
Bennett A, Patel H. Clinical Approaches to Hospital Medicine: Advances, Updates and Controversies. Chapter 1: Diagnosis and Treatment of Heart Failure for Inpatient Providers. 2017. ISBN 978-3-319-64774-6